The relationship between internalized stigma, negative symptoms and social functioning in schizophrenia: The mediating role of self-efficacy

Psychiatry Research

Volumn 206, Issue 2-3, 2013, Pages 151-157

  Hill, Kimberley ^a   Startup, Mike ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Internalized stigma; Negative symptoms; Schizophrenia; Self efficacy; Social functioning

Indexed keywords

ADULT; ANHEDONIA; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOSIS; QUESTIONNAIRE; SCHIZOPHRENIA; SELF CONCEPT; SOCIAL ADAPTATION; SOCIAL BEHAVIOR; SOCIAL PSYCHOLOGY; SOCIAL STIGMA;

ADULT; ANHEDONIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CONCEPT; SELF EFFICACY; SOCIAL ADJUSTMENT; SOCIAL BEHAVIOR; SOCIAL STIGMA; STEREOTYPING; YOUNG ADULT;

MLCS; MLOWN;

EID: 85027917322     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.09.056     Document Type: Article

References (42)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 2000, American Psychiatric Association, Washington, D.C.
2. Andreasen, N.C., Negative symptoms in schizophrenia. Definition and reliability. Archives of General Psychiatry 39 (1982), 784–788.
3. Avery, R., Startup, M., Calabria, K., The role of effort, cognitive expectancy appraisals and coping style in the maintenance of the negative symptoms of schizophrenia. Psychiatry Research 167 (2009), 36–46.
4. Bandura, A., Social Foundations of Thoughts and Action: A Social Cognitive Theory. 1986, Prentice Hall Inc., New York.
5. Baron-Cohen, S., O'Riordan, M., Stone, V., Jones, R., Plaisted, K., Recognition of Faux Pas by normally development children with children with Asperger Syndrome or high functioning autism. Journal of Autism and Developmental Disorders 29 (1999), 407–418.
6. Beck, A.T., Rector, N.A., Stolar, N., Grant, P., Schizophrenia: Cognitive Theory, Research, and Therapy. 2009, The Guilford Press, New York.
7. Bellack, A.S., Green, M.F., Cook, J.A., Fenton, W., Harvey, P.D., Heaton, R.K., Laughren, T., Leon, A.C., Mayo, D.J., Patrick, D.L., Patterson, T.L., Rose, A., Stover, E., Wykes, T., Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophrenia Bulletin 33 (2007), 805–822.
8. Bilker, W.B., Brensinger, C., Kurtz, M.M., Kohler, C., Gur, R.C., Siegel, S.J., Gur, R.E., Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology 28 (2003), 773–777.
9. Blanchard, J.J., Cohen, A.S., The structure of negative symptoms within schizophrenia: implications for assessment. Schizophrenia Bulletin 32 (2006), 238–245.
10. Buchanan, R.W., Persistent negative symptoms in schizophrenia: an overview. Schizophrenia Bulletin 33 (2007), 1013–1022.
11. Burns, T., Patrick, D., Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatrica Scandinavica 116 (2007), 403–418.
12. Corrigan, P.W., Penn, D.L., Introduction: framing models of social cognition and schizophrenia. Corrigan, P.W., Penn, D.L., (eds.) Social Cognition and Schizophrenia, 2001, American Psychological Association, Washington, 3–37.
13. Crawford, J.R., Besson, J.A.O., Bremner, M., Ebmeier, K.P., Cochrane, R.H.B., Kirkwood, K., Estimation of premorbid intelligence in schizophrenia. British Journal of Psychiatry 161 (1992), 69–74.
14. Fitzgerald, P.B., Rolfe, T.J., Brewer, K., Filia, K., Collins, J., Filia, S., Adams, A., de Castella, A.R., Davey, P., Kulkarni, J., Depressive, positive, negative and parkinsonian symptoms in schizophrenia. Australian and New Zealand Journal of Psychiatry 36 (2002), 340–346.
15. Foussias, G., Remington, G., Negative symptoms in schizophrenia: Avolition and Occam's razor. Schizophrenia Bulletin 36 (2010), 359–369.
16. Grant, P.M., Beck, A.T., Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophrenia Bulletin 35 (2009), 798–806.
17. Green, M.F., Nuechterlein, K.H., Should schizophrenia be treated as a neurocognitive disorder?. Schizophrenia Bulletin 25 (1999), 309–319.
18. Harvey, P.D., Koren, D., Reichenberg, A., Bowie, C.R., Negative symptoms and cognitive deficits: What is the nature of their relationship?. Schizophrenia Bulletin 32:2 (2006), 250–258.
19. Herbener, E.S., Harrow, M., Longitudinal assessment of negative symptoms in Schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients. Schizophrenia Bulletin 27:3 (2001), 527–537.
20. Karidi, M.V., Stefanis, C.N., Theleritis, C., Tzedaki, M., Rabavilas, A.D., Stefanis, N.C., Perceived social stigma, self-concept, and self-stigmatization of patient with schizophrenia. Comprehensive Psychiatry 51 (2010), 19–30.
21. Koren, D., Seidman, L.J., Goldsmith, M., Harvey, P.D., Real-world cognitive – and metacognitive – dysfunction in schizophrenia: a new approach for measuring (and remediating) more “right stuff”. Schizophrenia Bulletin 32 (2006), 310–326.
22. Lancon, C., Auquier, P., Reine, G., Bernard, D., Toumi, M., Study of the concurrent validity of the Calgary Depression Scale for schizophrenics (CDSS). Journal of Affective Disorders 58 (2000), 107–115.
23. Lysaker, P.H., Roe, D., Yanos, P.T., Toward understanding the insight paradox:iInternalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophrenia Bulletin 33 (2007), 192–199.
24. Lysaker, P.H., Vohs, J.L., Tsai, J., Negative symptoms and concordant impairments in attention in schizophrenia: associations with social functioning, hope, self-esteem and internalized stigma. Schizophrenia Research 110 (2009), 165–172.
25. Lysaker, P.H., Yanos, P.T., Outcalt, J., Roe, D., Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia. Clinical Schizophrenia and Related Psychoses 4 (2010), 41–48.
26. Martino, D.J., Bucay, D., Butman, J.T., Allegri, R.F., Neuropsychological frontal impairments and negative symptoms in schizophrenia. Psychiatry Research 152 (2007), 121–128.
27. Oosthuizen, P., Ernsley, R.A., Roberts, M.C., Turner, J., Keyter, L., Keyter, N., Torreman, M., Depressive symptoms at baseline predict fewer negative symptoms at follow-up in patients in first-episode schizophrenia. Schizophrenia Research 58 (2002), 247–252.
28. Perivoliotis, D., Morrison, A.P., Grant, P.M., French, P., Beck, A.T., Negative performance beliefs and negative symptoms in individuals at ultra-high risk of psychosis: a preliminary study. Psychopathology 774 (2008), 1–5.
29. Pratt, S.I., Mueser, K.T., Smith, T.E., Lu, W., Self-efficacy and psychosocial functioning in schizophrenia: a mediational analysis. Schizophrenia Research 78 (2005), 187–197.
30. Preacher, K.J., Hayes, A.F., SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods, Instruments and Computers 36 (2004), 717–731.
31. Rabinowitz, J., Reichenberg, A., Weiser, M., Mark, M., Kaplan, Z., Davidson, M., Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital: cross-sectional analysis. British Journal of Psychiatry 177 (2000), 26–32.
32. Rector, N.A., Beck, A.T., Stolar, N., The negative symptoms of schizophrenia: a cognitive perspective. Canadian Journal of Psychiatry 50 (2005), 247–257.
33. Ritsher, J.B., Otilingam, P.G., Grajales, M., Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Research 121 (2003), 31–49.
34. Rocca, P., Montemagni, C., Castagna, F., Giugiario, M., Scalese, M., Bogetto, F., Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 (2009), 373–379.
35. Sayers, S.L., Curran, P.J., Mueser, K.T., Factor structure and construct validity of the scale for the assessment of negative symptoms. Psychological Assessment 8 (1996), 269–280.
36. Sibitz, I., Unger, A., Woppmann, A., Zidek, T., Amering, M., Stigma resistance in patients with schizophrenia. Schizophrenia Bulletin 37 (2011), 316–323.
37. Siris, S.G., Depression in schizophrenia: perspective in the era of “atypical” antipsychotic agents. American Journal of Psychiatry 157 (2000), 1379–1389.
38. Startup, M., Jackson, M.C., Bendix, S., North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: outcomes at 6 and 12 months. Psychological Medicine 34 (2004), 413–422.
39. Startup, M., Jackson, M.C., Evans, K.E., Bendix, S., North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation. Psychological Medicine 35 (2005), 1307–1316.
40. Stone, V.E., Baron-Cohen, S., Knight, R.T., Frontal lobe contributions to theory of mind. Journal of Cognitive Neuroscience 10 (1998), 640–656.
41. Vauth, R., Kleim, B., Wirtz, M., Corrigan, P.W., Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia. Psychiatry Research 150 (2007), 71–80.
42. Yanos, P.T., Roe, D., Markus, K., Lysaker, P.H., Pathways between internalized stigma and outcomes related to recovery in schizophrenia spectrum disorders. Psychiatric Services 59 (2008), 1437–1442.